NXGL
NASD NexGel, Inc.$5.16 ↓ -0.12 (-2.27%) Trading Down from the previous close of $5.28, $0.34 below the day’s high of $5.50
- YTD change
- -83.97%
- vs 20-day SMA
- +22.43%
- vs 200-day SMA
- -62.39%
Price ranges
Price & Performance
+4.59 (+616.40%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 94.9% away from all-time highs of $102.00
- NXGL is down 84% since the beginning of the year
- NXGL is down 91% over the past 12 months
- NXGL is down 6% over the past 1 month
- 71% of all NXGL investors are betting against NXGL
NXGL reads not so good: price sits above one of the two key moving averages, the 12-month move is +91.7%.
- Previous minute
- +$0.00
- Last hour
- -$0.12
- Last 5 days
- +27.41%
- vs 8-day SMA
- +5.24%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
NexGel, Inc. engages in the manufacture of aqueous polymer hydrogels used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. It operates through the NexGel and CGN segments. The NexGel segment consists of the manufacturing of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, which is based in Langhorne, Pennsylvania. The CGN segment consists of the CGN JV used for the company’s converting and packaging business, which is based in Granbury, Texas. The company was founded on January 13, 2009, and is headquartered in Langhorne, PA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
